How to manage a 65-year-old with chest infection, productive cough, SOB (shortness of breath), and wheeze, with a history of asthma, hypertension, and hyperlipidemia, on salbutamol (albuterol), Amlodipine, chlorthalidone, Flixonase (fluticasone), rosuvastatin, aspirin, montelukast, quinapril, metformin, and Relvar Ellipta (fluticasone/vilanterol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Chest Infection with Wheeze in a 65-Year-Old with Asthma History

This patient requires immediate antibiotic therapy for bacterial chest infection, intensified bronchodilator therapy with nebulized salbutamol 5 mg plus ipratropium bromide 500 mcg every 4-6 hours, and a short course of oral corticosteroids (prednisolone 30 mg daily for 7-14 days). 1

Immediate Antibiotic Therapy

Start antibiotics immediately for this acute bacterial chest infection with purulent sputum. 1

  • First-line choice: Amoxicillin or tetracycline unless previously used with poor response 1
  • Second-line alternatives: Broad-spectrum cephalosporin or newer macrolides if inadequate response to first-line agents or more severe presentation 1
  • The presence of green purulent sputum, night sweats, and bilateral crackles indicates bacterial infection requiring antimicrobial coverage 1

Intensified Bronchodilator Therapy

Escalate to nebulized bronchodilator therapy given the severity of symptoms with bilateral wheeze and crackles. 1

Nebulizer Regimen:

  • Salbutamol 5 mg via air-driven nebulizer every 4-6 hours 1
  • Add ipratropium bromide 500 mcg to the salbutamol given the moderate-to-severe presentation with bilateral signs 1
  • Use air-driven nebulizers (not oxygen-driven) to avoid potential CO2 retention in patients with possible COPD 1
  • Continue nebulized therapy for 24-48 hours or until clinical improvement, then step down to metered-dose inhalers 1

Critical Technical Points:

  • Nebulize until approximately one minute after "spluttering" occurs (5-10 minutes total) 1
  • Do NOT use "dryness" as the endpoint 1
  • Tap the nebulizer cup toward the end of treatment 1

Systemic Corticosteroid Therapy

Initiate oral prednisolone 30 mg daily for 7-14 days. 1

  • This is indicated for acute exacerbations with marked wheeze and bilateral chest signs 1
  • Can use 100 mg hydrocortisone IV if oral route not possible 1
  • Discontinue after the acute episode unless long-term benefit has been demonstrated during stable periods 1
  • A corticosteroid trial during acute exacerbation does NOT automatically indicate need for long-term inhaled corticosteroids 1

Distinguishing Asthma vs COPD

The spirometry referral is appropriate and essential, but do not delay treatment. 1

Key Diagnostic Considerations:

  • COPD criteria: FEV1 <80% predicted AND FEV1/VC ratio <70% with fixed obstruction 1
  • Asthma features: Substantial bronchodilator reversibility (FEV1 increase ≥200 ml AND ≥15% from baseline) 1
  • This patient's 4-year smoking cessation and history of asthma with previous good response to bronchodilators suggests asthma, but the ex-smoking history raises COPD possibility 1
  • Many patients show overlap features, and 10-20% of COPD patients demonstrate some corticosteroid responsiveness 1

Monitoring and Reassessment

Reassess within 48 hours for home-managed exacerbations. 1

Signs Requiring Hospital Referral:

  • Worsening breathlessness despite treatment 1
  • Inability to complete sentences 1
  • Respiratory rate >25/min 1
  • Heart rate >110/min 1
  • Oxygen saturation declining below 90% 1
  • Development of confusion or drowsiness 1

Continuation of Existing Therapy

Continue all current medications without interruption. 1

  • Maintain Relvar Ellipta (fluticasone/vilanterol) for baseline asthma control 1
  • Continue salbutamol PRN, but frequency should decrease as infection resolves 2
  • Keep montelukast 10 mg daily 1
  • All cardiovascular medications (amlodipine, chlorthalidone, quinapril, rosuvastatin, aspirin) should continue 1

Blood Pressure Management

The elevated BP (157/92 mmHg) requires attention but is likely exacerbated by acute illness and bronchodilator therapy. 1

  • Beta-agonists can precipitate tachycardia and hypertension 1
  • Reassess BP after acute infection resolves before adjusting antihypertensive regimen 1
  • Salt restriction as planned is appropriate 1

Common Pitfalls to Avoid

  • Do not use albuterol alone for chronic cough not due to asthma - it is ineffective 1
  • Do not rely on metered-dose inhalers during acute exacerbations - nebulizers deliver superior drug deposition when significant bronchospasm present 1, 2
  • Do not use oxygen-driven nebulizers if COPD suspected - risk of CO2 retention 1
  • Do not delay antibiotics - purulent sputum with systemic symptoms requires immediate antimicrobial therapy 1
  • Avoid sedatives and hypnotics during acute exacerbation as they can suppress respiratory drive 1

Sputum Clearance

Encourage active coughing and adequate fluid intake. 1

  • Consider home physiotherapy if sputum retention problematic 1
  • Huffing technique may be taught as adjunct to coughing 1
  • Chest physiotherapy has limited evidence in acute COPD exacerbations but may help with sputum clearance 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Expiratory Wheezes Without Distress

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.